Feasibility of Using NeuraSignal Transcranial Doppler Robot
2 other identifiers
observational
20
1 country
1
Brief Summary
The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2024
CompletedFirst Posted
Study publicly available on registry
August 22, 2024
CompletedStudy Start
First participant enrolled
June 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2027
May 8, 2026
June 1, 2025
6 months
July 23, 2024
May 4, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Primary outcome
Cerebral autoregulatory curve generation using the NeuraSignal transcranial doppler robot correlated with arterial blood pressure measurements in neuro ICU patients admitted for blood pressure management after spinal surgery
one year
Secondary Outcomes (1)
Secondary outcome
one year
Study Arms (1)
Study Group
Using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves.
Interventions
measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves
Eligibility Criteria
Patients admitted to the Neuro ICU for blood pressure management (MAP management) after spinal surgery
You may qualify if:
- Patients admitted to the Neuro ICU for blood pressure management (MAP management) after spinal surgery
You may not qualify if:
- Patients under 18 years (or bodyweight \<50kg if age unknown),
- prisoners
- pregnant women,
- non-English speaking,
- patients enrolled in concurrent
- ongoing interventional trial
- students of UAB
- employees of UAB
- targeting specific populations
- patients with previously diagnosed brain pathology
- patients with open wounds over temporal bones precluding transcranial doppler
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UAB Department of Anesthesiology and Perioperative Medicine
Birmingham, Alabama, 35249, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Emily A Wasson, MD,MPH
University of Alabama at Birmingham
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, MPH Assistant Professor Division of Critical Care Department of Anesthesiology and Perioperative Medicine
Study Record Dates
First Submitted
July 23, 2024
First Posted
August 22, 2024
Study Start
June 15, 2026
Primary Completion (Estimated)
December 14, 2026
Study Completion (Estimated)
December 15, 2027
Last Updated
May 8, 2026
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
To be determined.